Twitter Facebook LinkedIn YouTube

Latest Video

FSD Pharma and SciCann Therapeutics Launch Clinical Cannabis-based Research Program in Israel

Video Platform Video Management Video Solutions Video Player

FSD Pharma Inc. (CSE:HUGE) (FSE:0K9) (OTCpink:FSDDF) has launched a clinical research collaborative program in Israel, via its strategic R&D partner, SciCann Therapeutics Inc. This comprehensive clinical research program will be executed through SciCann's strategic alliance and collaboration agreement with Mor Research Applications Ltd. - the technology transfer office and commercial arm of Clalit Healthcare Services.